newsfilter
← Latest News
GlobeNewswire·

Vaxxinity Receives FDA Fast Track Designation for UB-311 for Treatment of Alzheimer's Disease

DALLAS, May 02, 2022 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (NASDAQ:VAXX), a company pioneering the development of a new class of immunotherapeutic vaccines, today announced that UB-311, an anti-amyloid beta immunotherapeutic vaccine, has been granted Fas